No statistically significant deterioration in lung function seen following COVID-19, regardless of severity
High Viral Load in Lungs Linked to COVID-19 Mortality
No association seen for acquisition of hospital-acquired respiratory pathogen with fatal outcomes for patients with COVID-19
Outcomes Similar With CPAP, Oxygen Therapy for Severe COVID-19
Clinical outcomes compared in retrospective cohort study of COVID-19 patients deemed unlikely to benefit from invasive mechanical ventilation
New Symptoms, Disability Linger One Month After COVID-19 Discharge
Longer hospital stays tied to greater odds of one-month cardiopulmonary symptoms and new disability
Awake Prone Positioning May Prevent Intubation in COVID-19
Significant reduction seen in intubation with prone positioning for hospitalized patients with acute hypoxic respiratory failure
No Permanent Lung Damage Observed After COVID-19 Recovery
No difference seen between lung parenchyma of COVID-19 survivors and controls in specimens from unrelated elective lung resections
Antibiotic Dispensing Decreased After COVID-19 Restrictions
36 percent reduction seen in antibiotic dispensing after COVID-19 restrictions; large reduction found in antibiotics for RTIs
Preop Isolation May Up Risk for Postop Pulmonary Complications
Pandemic-related preoperative isolation linked to higher rates of postoperative pulmonary complications following elective surgery
AAP: Consider Palivizumab for Atypical Interseasonal RSV
AAP strongly supports consideration of palivizumab for patients who would be candidates per current eligibility recommendations
Transthoracic Echocardiography May ID Higher-Risk COVID-19 Patients
Reduced left ventricular ejection fraction, tricuspid annular plane systolic excursion tied to higher in-hospital mortality